Skip to main content
. 2022 Jul 18;17:127. doi: 10.1186/s13014-022-02098-z

Fig. 2.

Fig. 2

A Overall Survival between TIL(-) and TIL(+) in the whole cohort. B Progression-Free Survival between TIL(-) and TIL(+) in the whole cohort. C Brain Metastasis-Free Survival between TIL(-) and TIL(+) in the non-PCI and non-BM patients